Company profile
Pelthos Therapeutics Inc. Insider Trading
PTHSEvery SEC Form 4 insider trading filing for Pelthos Therapeutics Inc. (PTHS) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001919246
- Filings
- 58
- Insiders
- 13
- Last filing
- 2026-07-02
Activity summary
No insider transactions in the last 30 days. The most recent was on July 2, 2026, when Pauls Matthew sold 94 shares. 58 filings from 13 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q1 24 to Q3 26. Pelthos Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1000K.
90 day insight
Over the last 90 days, Pelthos Therapeutics Inc. insiders bought $1000K across 2 transactions with no open-market sales.
- Most active insider: Friedberg Ezra M with 4 transactions totaling $22K.
- Largest single purchase: $986K by Davis Todd C on Jun 11, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Pauls Matthew | PTHS | Sale10b5 | 94 | $27.36 | $3K |
| Jul 2, 2026 | Greenleaf Peter | PTHS | Sale10b5 | 85 | $27.27 | $2K |
| Jul 2, 2026 | Greenleaf Peter | PTHS | Sale10b5 | 712 | $26.00 | $19K |
| Jul 2, 2026 | Pauls Matthew | PTHS | Sale10b5 | 692 | $26.00 | $18K |
| Jul 2, 2026 | Friedberg Ezra M | PTHS | Sale10b5 | 534 | $26.03 | $14K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=PTHS" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Pelthos Therapeutics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →